Patent US7524331B2 successfully refreshed from Google Patents.
← Back to Patent Explorer
US7524331B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Catheter delivered valve having a barrier to provide an enhanced seal

Assignee: Medtronic Vascular Inc
•
Filing: 2006-04-06
•
Granted: 2009-04-28
•
Expires: 2026-04-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A system for treating abnormalities of the right ventricular outflow tract includes a prosthetic valve device having a barrier material contacting at least a portion of the outer surface of the valve device. One embodiment of the invention includes a barrier member attached to the exterior surface of the valve device. Another embodiment includes a barrier material that is injected within the vascular system. Yet another embodiment of the invention includes a method for replacing a pulmonary valve that includes forming a barrier around the outer surface of a replacement valve and preventing blood flow around the replacement valve.

Inventors

  • 👤 Matthew J. Birdsall

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 03:16
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2412; A61F2/2427; A61F2/2436; A61L; A61L27/00; A61L27/28; A61L27/30; A61L27/303; A61L27/34; A61F2/04; A61F2/06; A61F2/2418; A61F2/2475; A61F2/07; A61F2002/077; A61F2210/00; A61F2210/0061; A61F2250/00; A61F2250/0058; A61F2250/0069

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 153 words
A vascular valve replacement system, the system comprising: an implantable conduit having a conduit wall; a catheter; a prosthetic valve device including a valve connected to a support structure, the valve device disposed on the catheter; and a barrier member disposed about an outer surface of the support structure of the valve device, the barrier member comprising a layer of material that will fill space between the valve support structure and the conduit wall when the support structure is deployed in the implantable conduit, wherein the barrier member comprises directionally oriented microfibers and wherein the directionally oriented microfibers comprise a material selected from a group consisting of carbon, silica, polyester, nylon, polyamides, polyolefins, polyurethanes, and mixtures thereof, wherein when the prosthetic valve device is deployed from the catheter in the implantable conduit, the barrier member prevents blood flow between the conduit and the outer surface of the support structure of the valve device.
Claim 2
Dependent Claim 153 words
A vascular valve replacement system, the system comprising: an implantable conduit having a conduit wall; a catheter; a prosthetic valve device including a valve connected to a support structure, the valve device disposed on the catheter; and a barrier member disposed about an outer surface of the support structure of the valve device, the barrier member comprising a layer of material that will fill space between the valve support structure and the conduit wall when the support structure is deployed in the implantable conduit, wherein the barrier member comprises directionally oriented microfibers and wherein the directionally oriented microfibers comprise a material selected from a group consisting of carbon, silica, polyester, nylon, polyamides, polyolefins, polyurethanes, and mixtures thereof, wherein when the prosthetic valve device is deployed from the catheter in the implantable conduit, the barrier member prevents blood flow between the conduit and the outer surface of the support structure of the valve device.
Claim 3
Dependent Claim 127 words
A vascular valve replacement system, the system comprising: an implantable conduit having a conduit wall; a catheter; a prosthetic valve device including a valve connected to a support structure, the valve device disposed on the catheter; and a barrier member disposed about an outer surface of the support structure of the valve device, the barrier member comprising a layer of material that will fill space between the valve support structure and the conduit wall when the support structure is deployed in the implantable conduit, wherein the barrier member comprises polyester batting, wherein when the prosthetic valve device is deployed from the catheter in the implantable conduit, the barrier member prevents blood flow between the conduit and the outer surface of the support structure of the valve device.
Claim 4
Dependent Claim 127 words
A vascular valve replacement system, the system comprising: an implantable conduit having a conduit wall; a catheter; a prosthetic valve device including a valve connected to a support structure, the valve device disposed on the catheter; and a barrier member disposed about an outer surface of the support structure of the valve device, the barrier member comprising a layer of material that will fill space between the valve support structure and the conduit wall when the support structure is deployed in the implantable conduit, wherein the barrier member comprises polyester batting, wherein when the prosthetic valve device is deployed from the catheter in the implantable conduit, the barrier member prevents blood flow between the conduit and the outer surface of the support structure of the valve device.
Claim 5
Dependent Claim 156 words
A vascular valve replacement system, the system comprising: an implantable conduit having a conduit wall; a catheter; a prosthetic valve device including a valve connected to a support structure, the valve device disposed on the catheter; and a barrier member disposed about an outer surface of the support structure of the valve device, the barrier member comprising a layer of material that will fill space between the valve support structure and the conduit wall when the support structure is deployed in the implantable conduit, wherein the barrier member is a compressible foam matrix, and wherein the compressible foam matrix comprises a material selected from a group consisting of open cell sponge, polyurethane foam, collagen, polyvinyl alcohol, and poly (2-hydroxyethyl methacrylate), wherein when the prosthetic valve device is deployed from the catheter in the implantable conduit, the barrier member prevents blood flow between the conduit and the outer surface of the support structure of the valve device.
Claim 6
Dependent Claim 156 words
A vascular valve replacement system, the system comprising: an implantable conduit having a conduit wall; a catheter; a prosthetic valve device including a valve connected to a support structure, the valve device disposed on the catheter; and a barrier member disposed about an outer surface of the support structure of the valve device, the barrier member comprising a layer of material that will fill space between the valve support structure and the conduit wall when the support structure is deployed in the implantable conduit, wherein the barrier member is a compressible foam matrix, and wherein the compressible foam matrix comprises a material selected from a group consisting of open cell sponge, polyurethane foam, collagen, polyvinyl alcohol, and poly (2-hydroxyethyl methacrylate), wherein when the prosthetic valve device is deployed from the catheter in the implantable conduit, the barrier member prevents blood flow between the conduit and the outer surface of the support structure of the valve device.
Claim 7
Dependent Claim 18 words
The system of claim 3 wherein the volume of the compressible foam matrix increases upon exposure to water.
Claim 8
Dependent Claim 21 words
The system of claim 3 wherein the barrier member prevents the valve device from migrating along the length of the conduit.
Claim 9
Dependent Claim 98 words
A pulmonary valve replacement system, the system comprising: an implantable conduit having a lumen defined by an inner wall; a catheter; a prosthetic valve device including a valve connected to a support structure, the valve device positioned in the conduit, and a barrier disposed about at least a portion of an outer surface of the support structure, wherein the baffler is deployed via the catheter between the inner wall of the conduit and the outer surface of the support structure of the valve device to prevent blood flow there between and wherein the barrier is a helical coil.
Claim 10
Dependent Claim 98 words
A pulmonary valve replacement system, the system comprising: an implantable conduit having a lumen defined by an inner wall; a catheter; a prosthetic valve device including a valve connected to a support structure, the valve device positioned in the conduit, and a barrier disposed about at least a portion of an outer surface of the support structure, wherein the baffler is deployed via the catheter between the inner wall of the conduit and the outer surface of the support structure of the valve device to prevent blood flow there between and wherein the barrier is a helical coil.
Claim 11
Dependent Claim 30 words
The system of claim 6 wherein the helical coil comprises one or more materials selected from a group consisting of platinum, nitinol, platinum-iridium alloy, polyvinyl acid, polyvinyl pyrolidone and collagen.
Claim 12
Dependent Claim 32 words
The system of claim 6 wherein the helical coil promotes blood clotting between the inner wall of the conduit and at least a portion of the outer surface of the support structure.
Claim 13
Independent Claim 108 words
A method for replacing a pulmonary valve, the method comprising: delivering a prosthetic valve device including a valve connected to a support structure having a barrier disposed about at least a portion of an outer surface of the support structure to a treatment site within an implantable conduit via catheter; deploying the prosthetic valve device from the catheter; positioning the prosthetic valve device within the implantable conduit; forming a barrier around the outer surface of the support structure; and preventing blood flow around the support structure via the barrier and wherein forming a barrier further comprises increasing the volume of the barrier member by expanding a foam matrix.
Claim 14
Independent Claim 108 words
A method for replacing a pulmonary valve, the method comprising: delivering a prosthetic valve device including a valve connected to a support structure having a barrier disposed about at least a portion of an outer surface of the support structure to a treatment site within an implantable conduit via catheter; deploying the prosthetic valve device from the catheter; positioning the prosthetic valve device within the implantable conduit; forming a barrier around the outer surface of the support structure; and preventing blood flow around the support structure via the barrier and wherein forming a barrier further comprises increasing the volume of the barrier member by expanding a foam matrix.
Claim 15
Independent Claim 123 words
A method for replacing a pulmonary valve, the method comprising: delivering a prosthetic valve device including a valve connected to a support structure having a barrier disposed about at least a portion of an outer surface of the support structure to a treatment site within an implantable conduit via catheter; deploying the prosthetic valve device from the catheter; positioning the prosthetic valve device within the implantable conduit; forming a barrier around the outer surface of the support structure; and preventing blood flow around the support structure via the barrier and wherein forming a barrier further comprises deploying the barrier material from a catheter and placing the barrier material between the outer surface of the support structure and the inner wall of the conduit.
Claim 16
Independent Claim 123 words
A method for replacing a pulmonary valve, the method comprising: delivering a prosthetic valve device including a valve connected to a support structure having a barrier disposed about at least a portion of an outer surface of the support structure to a treatment site within an implantable conduit via catheter; deploying the prosthetic valve device from the catheter; positioning the prosthetic valve device within the implantable conduit; forming a barrier around the outer surface of the support structure; and preventing blood flow around the support structure via the barrier and wherein forming a barrier further comprises deploying the barrier material from a catheter and placing the barrier material between the outer surface of the support structure and the inner wall of the conduit.
Claim 17
Dependent Claim 19 words
The method of claim 10 further comprising preventing the prosthetic valve from migrating along the length of the conduit.
Claim 18
Dependent Claim 46 words
The method of claim 10 wherein forming a barrier around the outer surface of the support structure maintains the prosthetic valve in a fixed position that is perpendicular to the direction of blood flow within the vascular conduit and thereby improves the functioning of the valve.

References Cited (Backward Citations)

US3334629A Cited
US3540431A Cited
US3671979A Cited
US3628535A Cited
US3642004A Cited
US3657744A Cited
US3868956A Cited
US3839741A Cited
US3795246A Cited
US3874388A Cited
US4291420A Cited
US4106129A Cited
US4056854A Cited
US4233690A Cited
US4501030A Cited
US4425908A Cited
US4647283A Cited
US4648881A Cited
US4655771B1 Cited
US4954126A Cited
US4655771A Cited
US4954126B1 Cited
US4610688A Cited
US4834755A Cited
US4665906A Cited
US4580568A Cited
US4662885A Cited
US4733665B1 Cited
US4733665A Cited
US4733665C2 Cited
US4710192A Cited
US4872874A Cited
US4819751A Cited
US5156621A Cited
US4909252A Cited
US4917102A Cited
US4856516A Cited
US4994077A Cited
US5002559A Cited
US5840081A Cited
US6168614B1 Cited
US5411552A Cited
US5197979A Cited
US5336258A Cited
US5217483A Cited
US5161547A Cited
US5397351A Cited
US5350398A Cited
US5713953A Cited
US5370685A Cited
US20020058995A1 Cited
EP0937439B1 Cited
US6338735B1 Cited
US5507767A Cited
US5800456A Cited
WO1993015693A1 Cited
US5163953A Cited
US5876448A Cited
US5645559A Cited
US5332402A Cited
US5431676A Cited
WO1995004556A3 Cited
US5545211A Cited
US5389106A Cited
US20040088045A1 Cited
US6719789B2 Cited
US6673109B2 Cited
US6736846B2 Cited
EP1340473A2 Cited
US5824043A Cited
US6350282B1 Cited
US5693085A Cited
WO1995029640A1 Cited
US5824056A Cited
US5860996A Cited
US5554185A Cited
WO1996014032A1 Cited
US5674277A Cited
US5575818A Cited
EP0810913B1 Cited
US5667523A Cited
US5824064A Cited
US6327772B1 Cited
US5907893A Cited
US5888201A Cited
US5695498A Cited
US5891191A Cited
US6592546B1 Cited
US6027525A Cited
US5855601A Cited
US20010025196A1 Cited
US6702851B1 Cited
US5861028A Cited
US20050251251A1 Cited
US20030109924A1 Cited
US20010007956A1 Cited
US20030014104A1 Cited
US6241757B1 Cited
WO1998036790A1 Cited
US6530949B2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2012-04-27 2012-10-27 2013-04-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2016-04-27 2016-10-27 2017-04-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2020-04-27 2020-10-27 2021-04-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag